Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01 Por [email protected] Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01 Read More »
Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study Por [email protected] Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study Read More »
Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer Por [email protected] Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer Read More »
Axillary de-escalation after neoadjuvant chemotherapy for advanced lymph node involvement in breast cancer Por [email protected] Axillary de-escalation after neoadjuvant chemotherapy for advanced lymph node involvement in breast cancer Read More »
Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study Por [email protected] Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study Read More »
Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged ≥90 Years: A Large Retrospective Cohort Study Por [email protected] Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged ≥90 Years: A Large Retrospective Cohort Study Read More »
What is the Optimum Timing of Post-mastectomy Radiotherapy in Two-stage Prosthetic Reconstruction: Radiation to the Tissue Expander or Permanent Implant? Por [email protected] What is the Optimum Timing of Post-mastectomy Radiotherapy in Two-stage Prosthetic Reconstruction: Radiation to the Tissue Expander or Permanent Implant? Read More »
Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction Por [email protected] Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction Read More »
Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women’s Health Initiative Randomized Trials Por [email protected] Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women’s Health Initiative Randomized Trials Read More »
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial Por [email protected] Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial Read More »
Review of Outcomes in Prepectoral Prosthetic Breast Reconstruction with and without Surgical Mesh Assistance Por [email protected] Review of Outcomes in Prepectoral Prosthetic Breast Reconstruction with and without Surgical Mesh Assistance Read More »
Trastuzumab deruxtecan for the treatment of patients with HER2‑positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET‑BM) Por [email protected] Trastuzumab deruxtecan for the treatment of patients with HER2‑positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET‑BM) Read More »
